Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB for Chronic lymphocytic leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,537 adverse event reports in the FDA FAERS database where IDELALISIB was used for Chronic lymphocytic leukaemia.

Most Reported Side Effects for IDELALISIB

Side Effect Reports % Deaths Hosp.
Disease progression 1,204 17.6% 139 130
Death 779 11.4% 779 117
Diarrhoea 752 11.0% 87 510
Off label use 548 8.0% 85 159
Pneumonia 426 6.2% 140 311
Pyrexia 371 5.4% 44 290
Drug ineffective 294 4.3% 62 63
Fatigue 284 4.1% 29 132
Dehydration 242 3.5% 22 212
Dyspnoea 206 3.0% 41 143
Neutropenia 204 3.0% 47 100
Colitis 201 2.9% 41 133
Pneumonitis 199 2.9% 57 133
Asthenia 193 2.8% 22 138
Rash 168 2.5% 27 63

Other Indications for IDELALISIB

B-cell lymphoma (1,240) Product used for unknown indication (551) Non-hodgkin's lymphoma (373) Lymphoma (301) Follicular lymphoma (200) Non-hodgkin's lymphoma unspecified histology indolent (164) Waldenstrom's macroglobulinaemia (88) Leukaemia (74) Diffuse large b-cell lymphoma (66) B-cell small lymphocytic lymphoma (65)

Other Drugs Used for Chronic lymphocytic leukaemia

IBRUTINIB (37,003) VENETOCLAX (14,194) RITUXIMAB (7,231) OBINUTUZUMAB (4,557) ACALABRUTINIB (4,515) CYCLOPHOSPHAMIDE (3,085) FLUDARABINE (2,777) BENDAMUSTINE (2,561) CHLORAMBUCIL (1,242) OFATUMUMAB (1,216)

Related Pages

IDELALISIB Full Profile All Chronic lymphocytic leukaemia Drugs IDELALISIB Demographics IDELALISIB Timeline